{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:05:57Z","timestamp":1790208357303,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00592-019-01467-7","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T18:08:30Z","timestamp":1577988510000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Tasnim","family":"Alkayyali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Qutranji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Bakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-5283","authenticated-orcid":false,"given":"Yusuf","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"1467_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357","journal-title":"Hepatology"},{"key":"1467_CR2","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2019.18045","author":"E Kaya","year":"2019","unstructured":"Kaya E, Y\u0131lmaz Y (2019) Non-alcoholic fatty liver disease: a growing public health problem in Turkey. Turk J Gastroenterol. https:\/\/doi.org\/10.5152\/tjg.2019.18045","journal-title":"Turk J Gastroenterol"},{"key":"1467_CR3","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, et al. (2019) Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology 69:2672\u20132682","journal-title":"Hepatology"},{"key":"1467_CR4","doi-asserted-by":"publisher","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","volume":"96","author":"W Dai","year":"2017","unstructured":"Dai W, Ye L, Liu A, et al. (2017) Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore) 96:e8179","journal-title":"Medicine (Baltimore)"},{"key":"1467_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14734","author":"T Tada","year":"2019","unstructured":"Tada T, Toyoda H, Sone Y, et al. (2019) Type 2 diabetes mellitus: a risk factor for progression of liver fibrosis in middle-aged patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.14734","journal-title":"J Gastroenterol Hepatol"},{"key":"1467_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","volume":"10","author":"Q Li","year":"2018","unstructured":"Li Q, Dhyani M, Grajo JR, et al. (2018) Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol 10:530\u2013542","journal-title":"World J Hepatol"},{"key":"1467_CR7","doi-asserted-by":"publisher","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","volume":"21","author":"P St\u00e5l","year":"2015","unstructured":"St\u00e5l P (2015) Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol 21:11077\u201311087","journal-title":"World J Gastroenterol"},{"key":"1467_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jhep.2013.10.017","volume":"60","author":"JR Morling","year":"2014","unstructured":"Morling JR, Fallowfield JA, Guha IN, et al. (2014) Edinburgh type 2 diabetes study investigators. Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol 60:384\u2013391","journal-title":"J Hepatol"},{"key":"1467_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, et al. (2011) Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54:344\u2013353","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1467_CR10","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62\u2013S69","journal-title":"Diabetes Care"},{"key":"1467_CR11","unstructured":"Swarup S, Zeltser R (2019) Metabolic syndrome. StatPearls. The US National Library of Medicine; [updated 2019 Feb 28; cited 2019 May 28]. www.ncbi.nlm.nih.gov\/books\/NBK459248\/"},{"key":"1467_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. (2009) Nash clinical research network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7:1104\u20131112","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1467_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846\u2013854","journal-title":"Hepatology"},{"key":"1467_CR14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, et al. (2012) Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56:1751\u20131759","journal-title":"Hepatology"},{"key":"1467_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Nonalcoholic steatohepatitis clinical research network. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"1467_CR16","doi-asserted-by":"crossref","unstructured":"Richards JA (2013) Remote sensing digital image analysis: an introduction, 5th edn. Springer, Berlin","DOI":"10.1007\/978-3-642-30062-2"},{"key":"1467_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.21984","volume":"47","author":"IN Guha","year":"2008","unstructured":"Guha IN, Parkes J, Roderick P, et al. (2008) Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47:455\u2013460","journal-title":"Hepatology"},{"key":"1467_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/MEG.0b013e32835d72cf","volume":"25","author":"S McPherson","year":"2013","unstructured":"McPherson S, Anstee QM, Henderson E, et al. (2013) Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? Eur J Gastroenterol Hepatol 25:652\u2013658","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1467_CR19","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388\u2013402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"1467_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149:389\u2013397","journal-title":"Gastroenterology"},{"key":"1467_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, et al. (2015) Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61:1547\u20131554","journal-title":"Hepatology"},{"key":"1467_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, Allen AM, Wang Z, et al. (2015) Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13:643\u2013654","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1467_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hep4.1342","volume":"3","author":"N Alkhouri","year":"2019","unstructured":"Alkhouri N, Lawitz E, Noureddin M (2019) Looking into the crystal ball: predicting the future challenges of fibrotic NASH treatment. Hepatol Commun 3:605\u2013613","journal-title":"Hepatol Commun"},{"key":"1467_CR24","first-page":"261","volume":"5","author":"MC Cheah","year":"2017","unstructured":"Cheah MC, McCullough AJ, Goh GB (2017) Current modalities of fibrosis assessment in non-alcoholic fatty liver disease. J Clin Transl Hepatol 5:261\u2013271","journal-title":"J Clin Transl Hepatol"},{"key":"1467_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","volume":"134","author":"M Friedrich-Rust","year":"2008","unstructured":"Friedrich-Rust M, Ong MF, Martens S, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960\u2013974","journal-title":"Gastroenterology"},{"key":"1467_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, et al. (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454\u2013462","journal-title":"Hepatology"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01467-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:45:33Z","timestamp":1609461933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1467"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01467-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of the Faculty of Medicine, Marmara University (Istanbul, Turkey).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}